Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takako Inoue

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
International Cancer Conference Journal|January 8, 2024
Relapsing cytokine release syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab and axitinib therapyAkihiro Yoshimura, Yoshiyuki Yamamoto, Tatsuya Nishikawa, et al.
Neuro-Oncology Advances|July 10, 2020
The impact of EGFR mutation status and single brain metastasis on the survival of non-small-cell lung cancer patients with brain metastasesYuya Fujita, Manabu Kinoshita, Tomohiko Ozaki, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2018
Gut Dysbiosis Associated With Hepatitis C Virus InfectionTakako Inoue, Jiro Nakayama, Kei Moriya, et al.
Investigational New Drugs|June 28, 2018
Proliferative CD8(+) PD-1(+) T-cell infiltration in a pembrolizumab-induced cutaneous adverse reactionKei Kunimasa, Taiki Isei, Harumi Nakamura, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related eventsKei Kunimasa, Harumi Nakamura, Kazuko Sakai, et al.
CJC Open|July 22, 2022
A Case of Lung Cancer with Very-Late-Onset Immune Checkpoint Inhibitor-Related MyocarditisTatsuya Nishikawa, Motohiro Tamiya, Keiko Ohta-Ogo, et al.
Plos One|January 25, 2017
Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based TherapyTakako Inoue, Su Su Hmwe, Noritomo Shimada, et al.
Anticancer Research|October 7, 2017
Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with NivolumabYoshihiko Taniguchi, Akihiro Tamiya, Syun-Ichi Isa, et al.
JTO Clinical and Research Reports|November 8, 2021
Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case ReportKei Kunimasa, Jiro Okami, Satoshi Takenaka, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 9, 2023
A longitudinal study to detect hepatitis B surface and core-related antigens in chronic hepatitis B patients with hepatitis B surface antigen seroclearance using highly sensitive assaysDanny Ka-Ho Wong, Takako Inoue, Lung-Yi Mak, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
International Cancer Conference Journal|January 8, 2024
Relapsing cytokine release syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab and axitinib therapyAkihiro Yoshimura, Yoshiyuki Yamamoto, Tatsuya Nishikawa, et al.
Neuro-Oncology Advances|July 10, 2020
The impact of EGFR mutation status and single brain metastasis on the survival of non-small-cell lung cancer patients with brain metastasesYuya Fujita, Manabu Kinoshita, Tomohiko Ozaki, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2018
Gut Dysbiosis Associated With Hepatitis C Virus InfectionTakako Inoue, Jiro Nakayama, Kei Moriya, et al.
Investigational New Drugs|June 28, 2018
Proliferative CD8(+) PD-1(+) T-cell infiltration in a pembrolizumab-induced cutaneous adverse reactionKei Kunimasa, Taiki Isei, Harumi Nakamura, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related eventsKei Kunimasa, Harumi Nakamura, Kazuko Sakai, et al.
CJC Open|July 22, 2022
A Case of Lung Cancer with Very-Late-Onset Immune Checkpoint Inhibitor-Related MyocarditisTatsuya Nishikawa, Motohiro Tamiya, Keiko Ohta-Ogo, et al.
Plos One|January 25, 2017
Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based TherapyTakako Inoue, Su Su Hmwe, Noritomo Shimada, et al.
Anticancer Research|October 7, 2017
Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with NivolumabYoshihiko Taniguchi, Akihiro Tamiya, Syun-Ichi Isa, et al.
JTO Clinical and Research Reports|November 8, 2021
Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case ReportKei Kunimasa, Jiro Okami, Satoshi Takenaka, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 9, 2023
A longitudinal study to detect hepatitis B surface and core-related antigens in chronic hepatitis B patients with hepatitis B surface antigen seroclearance using highly sensitive assaysDanny Ka-Ho Wong, Takako Inoue, Lung-Yi Mak, et al.
Pageof 15